The European Union’s drug regulator announced Friday it will not use batches of the Johnson & Johnson COVID-19 vaccine that were made at a Baltimore, Maryland-based plant around the time that manufacturing problems were reported at the facility.
The European Medicines Agency (EMA) said that vaccines that it obtained from the Emergent Biosolutions plant weren’t affected by any contamination. The move on Friday to suspend using the vaccines is being done out of an abundance of caution, the agency said.
